Northwest Investment Counselors’s Charles River Laboratories CRL Stock Holding History

Northwest Investment Counselors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$3.35K	Buy	+17	New	+$3.53K	﹤0.01%	526
2024 Q2	–	Sell	-17	Closed	-$4.61K	–	213
2024 Q1	$4.61K	Buy	+17	New	+$4.06K	﹤0.01%	440
2023 Q4	–	Sell	-17	Closed	-$3.33K	–	211
2023 Q3	$3.33K	Hold	17	–	–	﹤0.01%	484
2023 Q2	$3.57K	Hold	17	–	–	﹤0.01%	482
2023 Q1	$3.43K	Hold	17	–	–	﹤0.01%	484
2022 Q4	$3.7K	Hold	17	–	–	﹤0.01%	490
2022 Q3	$3K	Hold	17	–	–	﹤0.01%	467
2022 Q2	$4K	Hold	17	–	–	﹤0.01%	449
2022 Q1	$5K	Hold	17	–	–	﹤0.01%	460
2021 Q4	$6K	Buy	+17	New	+$6.61K	﹤0.01%	424
2021 Q2	–	Sell	-17	Closed	-$5K	–	200
2021 Q1	$5K	Buy	+17	New	+$4.72K	﹤0.01%	430
2020 Q4	–	Sell	-17	Closed	-$4K	–	197
2020 Q3	$4K	Buy	+17	New	+$3.53K	﹤0.01%	410
2019 Q4	–	Sell	-17	Closed	-$2K	–	217
2019 Q3	$2K	Buy	+17	New	+$2.28K	﹤0.01%	502

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Northwest Investment Counselors's CRL Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Charles River Laboratories (CRL) in Q3 2024: 17 shares worth $3.35K. The stake represents ﹤0.01% of the portfolio and ranks #526 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in CRL as recently as Q1 2024.

Northwest Investment Counselors first reported a position in CRL in Q3 2019 and has held it in 13 quarters since. The position peaked at $6K in Q4 2021. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

Northwest Investment Counselors held 17 shares of Charles River Laboratories worth $3.35K as of Q3 2024.
Charles River Laboratories was a new Northwest Investment Counselors position in Q3 2024.
Charles River Laboratories made up ﹤0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #526 holding.
Northwest Investment Counselors first reported a position in Charles River Laboratories in Q3 2019 and has held it in 13 quarters since.
Northwest Investment Counselors's Charles River Laboratories position peaked at $6K in Q4 2021.
628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.